Abstract LB-C09: The KRASG12Cinhibitor MRTX849 reconditions the tumor immune microenvironment and leads to durable complete responses in combination with anti-PD-1 therapy in a syngeneic mouse model

2019 ◽  
Author(s):  
David M Briere ◽  
Andrew Calinisan ◽  
Ruth Aranda ◽  
Niranjan Sudhakar ◽  
Lauren Hargis ◽  
...  
Keyword(s):  
Mouse Model ◽  
Immune Microenvironment ◽  
Syngeneic Mouse ◽  
Syngeneic Mouse Model ◽  
Tumor Immune Microenvironment

Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris

2011 ◽  
Vol 63 (1) ◽  
pp. 33-39 ◽  
Author(s):  
Tsuyoshi Hata ◽  
Koji Nishifuji ◽  
Kouji Shimoda ◽  
Takashi Sasaki ◽  
Taketo Yamada ◽  
...  
Keyword(s):  
Mouse Model ◽  
Pemphigus Vulgaris ◽  
Syngeneic Mouse ◽  
Syngeneic Mouse Model ◽  
Desmoglein 3

scholarly journals Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model

1999 ◽  
Vol 155 (6) ◽  
pp. 1861-1867 ◽  
Author(s):  
Rebecca Liu ◽  
Carmen Page ◽  
David R. Beidler ◽  
Max S. Wicha ◽  
Gabriel Núñez
Keyword(s):  
Mouse Model ◽  
Chemotherapy Resistance ◽  
Mammary Tumors ◽  
Syngeneic Mouse ◽  
Syngeneic Mouse Model

Impact of the Surgical Peritoneal Environment on Pre-implanted Tumors on a Molecular Level: A Syngeneic Mouse Model

2010 ◽  
Vol 162 (1) ◽  
pp. 79-87 ◽  
Author(s):  
Sachiko Matsuzaki ◽  
Anne-Sophie Azuar ◽  
Gérard Mage ◽  
Michel Canis
Keyword(s):  
Mouse Model ◽  
Molecular Level ◽  
Syngeneic Mouse ◽  
Syngeneic Mouse Model

Abstract 6697: DT095895, a selective EP4receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties

2020 ◽  
Author(s):  
Anne-Laure Blayo ◽  
Laurène Deshons ◽  
Alexia Dumont ◽  
Christel Franchet ◽  
Célia Halter ◽  
...  
Keyword(s):  
Mouse Model ◽  
Syngeneic Mouse ◽  
Syngeneic Mouse Model
Sign in / Sign up

Export Citation Format

Share Document